Michael Burgess actually said...

In that light, I believe any policies pursued by this committee must put the patient front and center.

It is especially important that as we evaluate this legislation we consider the unintended consequences for both the patient and the market.

It would be wrong for a formulary or an insurance company, anyone else, to change your patient's medication.

What I don't want to happen is that Congress overreacts.